These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8614796)

  • 1. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 2. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.
    Wolinsky SM; Korber BT; Neumann AU; Daniels M; Kunstman KJ; Whetsell AJ; Furtado MR; Cao Y; Ho DD; Safrit JT
    Science; 1996 Apr; 272(5261):537-42. PubMed ID: 8614801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 evolution and disease progression.
    Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ
    Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS: decline and fall of immune surveillance?
    Feinberg MB; McLean AR
    Curr Biol; 1997 Mar; 7(3):R136-40. PubMed ID: 9162473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants.
    Meier UC; Klenerman P; Griffin P; James W; Köppe B; Larder B; McMichael A; Phillips R
    Science; 1995 Nov; 270(5240):1360-2. PubMed ID: 7481824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS. Virological mayhem.
    Wain-Hobson S
    Nature; 1995 Jan; 373(6510):102. PubMed ID: 7816085
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.
    Buseyne F; Janvier G; Teglas JP; Ivanoff S; Burgard M; Bui E; Mayaux MJ; Blanche S; Rouzioux C; Rivière Y
    J Infect Dis; 1998 Oct; 178(4):1019-23. PubMed ID: 9806029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.
    Keet IP; Janssen M; Veugelers PJ; Miedema F; Klein MR; Goudsmit J; Coutinho RA; de Wolf F
    J Infect Dis; 1997 Sep; 176(3):665-71. PubMed ID: 9291313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV without AIDS but no AIDS without HIV].
    Soriano V; González-Lahoz J
    Med Clin (Barc); 1995 Jul; 105(5):172-3. PubMed ID: 7630229
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV progression to AIDS: bioinformatics approach to determining the mechanism of action.
    Nwankwo N; Seker H
    Curr HIV Res; 2013 Jan; 11(1):30-42. PubMed ID: 22998236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T-cell recognition of HIV proteins and peptides.
    Nixon DF; McMichael AJ
    AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV's other immune-system targets: macrophages.
    Balter M
    Science; 1996 Nov; 274(5292):1464-5. PubMed ID: 8966614
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV receptors and the pathogenesis of AIDS.
    Weiss RA
    Science; 1996 Jun; 272(5270):1885-6. PubMed ID: 8658158
    [No Abstract]   [Full Text] [Related]  

  • 19. Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression.
    Gange SJ; Mellors JW; Lau B; Detels R; Phair JP; Muñoz A; Margolick JB
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1223-9. PubMed ID: 11559421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
    Bariou C; Genetet N; Ruffault A; Michelet C; Cartier F; Genetet B
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1301-12. PubMed ID: 9339847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.